NEW YORK (GenomeWeb News) – The European Commission said today that it has pumped €144 million ($188 million) into a number of new research projects that will target rare diseases, including 'omics-centered studies and efforts to understand the genetic diseases and develop personalized strategies for treating and managing them.

The funding will support 26 research projects in 29 countries and involve more than 300 participants at academic institutions and patients' groups and in the business community who will share knowledge and resources to address rare diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.